Advanced Search

    column
    Immunotherapy Boost Perioperative “Weapons” in Lung Cancer
    CHEN Jing-hua, TANG Wen-fang, ZHONG Wen-zhao
    2019, 19(1): 1-3. DOI: 10.12019/j.issn.1671-5144.2019.01.001
    Abstract PDF
    2018 Research Advances in Lung Cancer
    TU Hai-yan, XU Bing-fei, WU Yi-long
    2019, 19(1): 4-9. DOI: 10.12019/j.issn.1671-5144.2019.01.002
    Abstract PDF
    2018 Clinical Research Advances of Breast Cancer
    CAO Li, LIAO Ning
    2019, 19(1): 10-13. DOI: 10.12019/j.issn.1671-5144.2019.01.003
    Abstract PDF
    Research Advances of Hematologic Tumor Immunological Treament in 2018
    CHEN Xiao-mei, LAI Pei-long, WENG Jian-yu, DU Xin
    2019, 19(1): 14-16. DOI: 10.12019/j.issn.1671-5144.2019.01.004
    Abstract PDF
    2018 Research Advances in Lymphoma Treatment
    LIU Si-chu, LI Wen-yu
    2019, 19(1): 17-20. DOI: 10.12019/j.issn.1671-5144.2019.01.005
    Abstract PDF
    Research Advances of Hepatocellular Carcinoma with Transarterial Chemoembolization in 2018
    HE Jian, CHEN Xiao-ming
    2019, 19(1): 21-22. DOI: 10.12019/j.issn.1671-5144.2019.01.006
    Abstract PDF
    2018 Clinical Research Advances in Gastrointestinal Cancer
    DONG Qiu-mei, MA Dong
    2019, 19(1): 23-25. DOI: 10.12019/j.issn.1671-5144.2019.01.007
    Abstract PDF
    Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
    WANG Chang-li, HAN Ying, ZHOU Jia-ying
    2019, 19(1): 26-29. DOI: 10.12019/j.issn.1671-5144.2019.01.008
    Abstract PDF
    Erlotinib Versus Standard First-Line Chemotherapy as Neoadjuvant Treatment for Stage ⅢA-N2 EGFR-Mutation Positive Non-Small Cell Lung Cancer
    KANG Xiao-zheng, YAN Wan-pu, CHEN Ke-neng, TANG Wen-fang
    2019, 19(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2019.01.009
    Abstract PDF
    Effect of Erlotinib in Patients with Resected Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
    YANG Fan, CHU Xiang-peng
    2019, 19(1): 34-38. DOI: 10.12019/j.issn.1671-5144.2019.01.010
    Abstract PDF
    Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK-Rearrangement: A Brief Report
    WANG Zhi-jie, FU Rui
    2019, 19(1): 39-43. DOI: 10.12019/j.issn.1671-5144.2019.01.011
    Abstract PDF
    Efficacy of Erlotinib Versus Vinorelbine Plus Cisplatin as Adjuvant Therapy for StageⅢA EGFR Mutation-Positive Non-Small Cell Lung Cancer
    YAN Xiao-long, XIA Jin
    2019, 19(1): 44-46. DOI: 10.12019/j.issn.1671-5144.2019.01.012
    Abstract PDF
    Efficacy and Safety of Target Controlled Infusion（TCI） Compared to Manually Controlled Infusion（MCI） with Propofol and Remifentanil for Total Intravenous Anesthesia: A Systematic Review
    CHEN Ya-yu, TAN Xiao-lu, ZHANG Xing-an
    2019, 19(1): 47-55. DOI: 10.12019/j.issn.1671-5144.2019.01.013
    Abstract PDF
    Application of Health Education Prescription Combined with Patient Record Book in The Treatment of Radioactive Oral Mucositis
    ZHAO Shun-zhen, YANG Cui-qin, YANG Yan-zhen, LI Jian-fang, CUI Qiu-xia
    2019, 19(1): 56-58. DOI: 10.12019/j.issn.1671-5144.2019.01.014
    Abstract PDF
    Evaluation and Analysis of The Rationality of Adjuvant Chemotherapy for Colon Cancer Patients in Jingxian Hospital in 2015
    ZHANG Kao-fei, WU Mei-lin, WANG Yang-kui, FU Chang-fang
    2019, 19(1): 59-64. DOI: 10.12019/j.issn.1671-5144.2019.01.015
    Abstract PDF